Key points are not available for this paper at this time.
Our data suggest that the administration of hWJ-MSC-derived exosomes represents a promising therapy to prevent and treat perinatal brain injury.
Share your take
Add a clinician perspective alongside expert commentary.
Thomi et al. (Thu,) studied this question.